We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

82 hedge funds and large institutions have $79.7M invested in Adverum Biotechnologies in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 11

25% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 20

8% more funds holding

Funds holding: 76 → 82 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

48% less capital invested

Capital invested by funds: $153M → $79.7M (-$73.2M)

71% less call options, than puts

Call options by funds: $343K | Put options by funds: $1.19M

Holders
82
Holders Change
+6
Holders Change %
+7.89%
% of All Funds
2.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
25
Reduced
20
Closed
11
Calls
$343K
Puts
$1.19M
Net Calls
-$845K
Net Calls Change
-$235K

Top Buyers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
+$7.23M
2
SM
Sabby Management
Florida
+$1.93M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.1M
4
JAM
JW Asset Management
Florida
+$1.06M
5
ARTA
A.R.T. Advisors
New York
+$523K

Top Sellers

Rank Fund Capital Flow
1
CCM
Cadian Capital Management
New York
-$7.9M
2
Axa
Axa
France
-$6.59M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$6.14M
4
OAM
Oxford Asset Management
United Kingdom
-$1.47M
5
NI
Numeric Investors
Massachusetts
-$1.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$19.9M -$34.2K -613 -0.2%
GPP
2
Great Point Partners
Connecticut
$6.7M +$7.23M +129,542 New
VM
3
VHCP Management
New York
$5.7M – – –
NI
4
Numeric Investors
Massachusetts
$5.09M -$1.18M -21,093 -18%
BFA
5
BlackRock Fund Advisors
California
$4.32M +$55.7K +997 +1%
Vanguard Group
6
Vanguard Group
Pennsylvania
$3.49M +$431K +7,721 +13%
SM
7
Sabby Management
Florida
$2.79M +$1.93M +34,550 +177%
Primecap Management
8
Primecap Management
California
$2.21M +$275K +4,920 +13%
BIT
9
BlackRock Institutional Trust
California
$2.17M -$9.66K -173 -0.4%
Connor, Clark & Lunn Investment Management (CC&L)
10
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.61M +$21.8K +390 +1%
VMI
11
VHCP Management II
New York
$1.45M – – –
State Street
12
State Street
Massachusetts
$1.45M +$181K +3,241 +13%
Renaissance Technologies
13
Renaissance Technologies
New York
$1.44M +$1.1M +19,660 +239%
GCM
14
Gruss Capital Management
New York
$1.34M – – –
WCM
15
Wildcat Capital Management
New York
$1.22M – – –
Millennium Management
16
Millennium Management
New York
$1.18M -$16.5K -295 -1%
BCM
17
Bridgeway Capital Management
Texas
$1.16M +$169K +3,020 +16%
Northern Trust
18
Northern Trust
Illinois
$1.11M -$13.1K -234 -1%
Goldman Sachs
19
Goldman Sachs
New York
$1.1M +$153K +2,735 +15%
PAM
20
Panagora Asset Management
Massachusetts
$1.04M +$281K +5,026 +33%
RA
21
Royce & Associates
New York
$1M -$348K -6,226 -24%
JAM
22
JW Asset Management
Florida
$982K +$1.06M +18,992 New
Norges Bank
23
Norges Bank
Norway
$865K – – –
RPAM
24
Rhenman & Partners Asset Management
Sweden
$796K – – –
DCM
25
DAFNA Capital Management
California
$727K – – –
1
2 3 4

ADVM Hedge Fund Activity: Q1 2016 in Review

82 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q1 2016, worth a combined $79.7M — down 48% from $153M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ADVM positions and 11 closed out — a net gain of 6 holders — while 25 added to existing stakes and 20 trimmed.

The largest buyer was Great Point Partners, opening a new position worth an estimated $7.23M. The largest seller was Cadian Capital Management, cutting an estimated $7.9M.

  • 82 institutional investors held Adverum Biotechnologies (ADVM) as of Q1 2016, up from 76 in Q4 2015.
  • Funds reported $79.7M of Adverum Biotechnologies stock for Q1 2016, down 48% quarter-over-quarter.
  • 17 funds opened new Adverum Biotechnologies positions in Q1 2016 and 11 closed out, a net change of +6 holders.
  • The largest Adverum Biotechnologies buyer in Q1 2016 was Great Point Partners, an estimated $7.23M added.
  • The largest Adverum Biotechnologies seller in Q1 2016 was Cadian Capital Management, an estimated $7.9M sold.

Based on aggregated 13F filings for Q1 2016.